Source author record

Eleazar Eskin

Eleazar Eskin appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

4works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2022arXiv

Packaging, containerization, and virtualization of computational omics methods: Advances, challenges, and opportunities

Omics software tools have reshaped the landscape of modern biology and become an essential component of biomedical research. The increasing dependence of biomedical scientists on these powerful tools creates a need for easier installation and greater usability. Packaging, virtualization, and containerization are different approaches to satisfy this need by wrapping omics tools in additional software that makes the omics tools easier to install and use. Here, we systematically review practices across prominent packaging, virtualization, and containerization platforms. We outline the challenges, advantages, and limitations of each approach and some of the most widely used platforms from the perspectives of users, software developers, and system administrators. We also propose principles to make packaging, virtualization, and containerization of omics software more sustainable and robust to increase the reproducibility of biomedical and life science research.

preprint2021arXiv

RNA-seq data science: From raw data to effective interpretation

RNA-sequencing (RNA-seq) has become an exemplar technology in modern biology and clinical applications over the past decade. It has gained immense popularity in the recent years driven by continuous efforts of the bioinformatics community to develop accurate and scalable computational tools. RNA-seq is a method of analyzing the RNA content of a sample using the modern sequencing platforms. It generates enormous amounts of transcriptomic data in the form of nucleotide sequences, known as reads. RNA-seq analysis enables the probing of genes and corresponding transcripts which is essential for answering important biological questions, such as detecting novel exons, transcripts, gene expressions, and studying alternative splicing structure. However, obtaining meaningful biological signals from raw data using computational methods is challenging due to the limitations of modern sequencing technologies. The need to leverage these technological challenges have pushed the rapid development of many novel computational tools which have evolved and diversified in accordance with technological advancements, leading to the current myriad population of RNA-seq tools. Our review provides a systemic overview of RNA-seq technology and 235 available RNA-seq tools across various domains published from 2008 to 2020, discussing the interdisciplinary nature of bioinformatics involved in RNA sequencing, analysis, and software development.

preprint2020arXiv

Metagenomics for clinical diagnostics: technologies and informatics

The human-associated microbiome is closely tied to human health and is of substantial clinical interest. Metagenomics-based tools are emerging for clinical diagnostics, tracking the spread of diseases, and surveillance of potential pathogens. In some cases, these tools are overcoming limitations of traditional clinical approaches. Metagenomics has limitations barring the tools from clinical validation. Once these hurdles are overcome, clinical metagenomics will inform doctors of the best, targeted treatment for their patients and provide early detection of disease. Here we present an overview of metagenomics methods with a discussion of computational challenges and limitations.

preprint2014arXiv

A general framework for meta-analyzing dependent studies with overlapping subjects in association mapping

Meta-analysis of genome-wide association studies is increasingly popular and many meta-analytic methods have been recently proposed. A majority of meta-analytic methods combine information from multiple studies by assuming that studies are independent since individuals collected in one study are unlikely to be collected again by another study. However, it has become increasingly common to utilize the same control individuals among multiple studies to reduce genotyping or sequencing cost. This causes those studies that share the same individuals to be dependent, and spurious associations may arise if overlapping subjects are not taken into account in a meta-analysis. In this paper, we propose a general framework for meta-analyzing dependent studies with overlapping subjects. Given dependent studies, our approach "decouples" the studies into independent studies such that meta-analysis methods assuming independent studies can be applied. This enables many meta-analysis methods, such as the random effects model, to account for overlapping subjects. Another advantage is that one can continue to use preferred software in the analysis pipeline which may not support overlapping subjects. Using simulations and the Wellcome Trust Case Control Consortium data, we show that our decoupling approach allows both the fixed and the random effects models to account for overlapping subjects while retaining desirable false positive rate and power.